BRCA2 and breast cancer: We undertook the Prospective Outcomes in Sporadic versus Hereditary breast cancer (POSH) study, the primary aim of which was to determine the effect of inherited BRCA1 or BRCA2 mutations on outcomes in patients with young-onset breast cancer.15, 16